Latest News and Press Releases

MELBOURNE, Australia, Feb. 19, 2018 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX:CUV) (XETRA-DAX:UR9) (NASDAQ INTERNATIONAL DESIGNATION ADR:CLVLY) today released its new global Company...

NEW YORK, NY--(Marketwired - January 09, 2018) - Artificial intelligence is the big buzzword now. Academic studies trumpet that A.I. will replace humans in the workplace at unprecedented rates, while...

JOHNSTOWN, Pa., March 7, 2016 (GLOBE NEWSWIRE) -- Concurrent Technologies Corporation (CTC) has been recognized by the Ethisphere Institute, a global leader in defining and advancing the standards of...

BOSTON, MA--(Marketwired - Jul 16, 2015) -  Eventide is pleased to announce the launch of their third mutual fund, the Eventide Multi-Asset Income Fund. The Multi-Asset Income Fund seeks...

BOSTON, MA--(Marketwired - Jul 15, 2015) - The Eventide Gilead Fund (NASDAQ: ETGLX), (NASDAQ: ETAGX) (ETCGX, ETILX) and Eventide Healthcare & Life Sciences Fund (NASDAQ: ETNHX), (NASDAQ: ETAHX)...

BOSTON, MA--(Marketwired - Jan 20, 2015) - The Eventide Gilead Fund (NASDAQ: ETILX), a mutual fund practicing values-based investing, was the best performing midcap growth mutual fund for 2014...

BOSTON, MA--(Marketwired - Apr 22, 2014) - The Eventide Gilead Fund (NASDAQ: ETGLX) and the Eventide Healthcare & Life Sciences Fund (NASDAQ: ETAHX) were both named "Category Kings" by the Wall...

BOSTON, MA--(Marketwired - Apr 10, 2014) - The Eventide Gilead Fund (NASDAQ: ETILX) was awarded the 2014 Lipper Fund Award for Best Mid-Cap Growth Fund for the three-year period, out of 336 eligible...

BOSTON, MA--(Marketwired - Jan 21, 2014) - The Eventide Gilead Fund's no-load share class (NASDAQ: ETGLX) and the Eventide Healthcare & Life Sciences Fund's no-load share class (NASDAQ: ETNHX)...